Bank of Montreal’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-26,600
Closed -$2.56M 3914
2025
Q4
$2.56M Sell
26,600
-13,400
-34% -$1.3M ﹤0.01% 1564
2025
Q3
$3.81M Hold
40,000
﹤0.01% 1419
2025
Q2
$3.49M Hold
40,000
﹤0.01% 1389
2025
Q1
$3.59M Buy
+40,000
New +$3.58M ﹤0.01% 1291
2020
Q3
Sell
-84,800
Closed -$7.64M 4863
2020
Q2
$7.64M Buy
+84,800
New +$8.13M 0.01% 968
2020
Q1
Sell
-268,100
Closed -$30.4M 4446
2019
Q4
$30.4M Buy
+268,100
New +$29.4M 0.02% 559
2019
Q2
Sell
-58,300
Closed -$5.31M 5001
2019
Q1
$5.31M Buy
58,300
+44,600
+326% +$3.99M ﹤0.01% 1129
2018
Q4
$1.25M Sell
13,700
-636,300
-98% -$59.5M ﹤0.01% 1783
2018
Q3
$63.9M Buy
+650,000
New +$60.1M 0.05% 314

Other funds holding MDT

Bank of Montreal's MDT Position: Q1 2026 in Review

Bank of Montreal reduced its Medtronic (MDT) stake by 5.1% in Q1 2026, selling an estimated $20M and leaving 3,893,787 shares worth $337M. The position accounts for 0.13% of the portfolio, ranked #144.

Bank of Montreal first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $587M in Q4 2020. 2,238 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Bank of Montreal held 3,893,787 shares of Medtronic worth $337M as of Q1 2026.
  • Bank of Montreal sold 208,554 Medtronic shares in Q1 2026, an estimated $20M.
  • Medtronic made up 0.13% of Bank of Montreal's portfolio in Q1 2026, its #144 holding.
  • Bank of Montreal first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Medtronic position peaked at $587M in Q4 2020.
  • 2,238 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.